Zimmer Biomet Holdings Inc. (ZBH): Price and Financial Metrics


Zimmer Biomet Holdings Inc. (ZBH): $117.22

2.22 (+1.93%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ZBH POWR Grades


  • Growth is the dimension where ZBH ranks best; there it ranks ahead of 76.28% of US stocks.
  • The strongest trend for ZBH is in Quality, which has been heading down over the past 179 days.
  • ZBH ranks lowest in Momentum; there it ranks in the 19th percentile.

ZBH Stock Summary

  • With a market capitalization of $27,105,213,323, Zimmer Biomet Holdings Inc has a greater market value than 90.22% of US stocks.
  • With a price/earnings ratio of 67.49, Zimmer Biomet Holdings Inc P/E ratio is greater than that of about 89.33% of stocks in our set with positive earnings.
  • In terms of twelve month growth in earnings before interest and taxes, Zimmer Biomet Holdings Inc is reporting a growth rate of -1,080.12%; that's higher than merely 2.03% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Zimmer Biomet Holdings Inc are PPG, WAB, TFX, SNN, and VTRS.
  • Visit ZBH's SEC page to see the company's official filings. To visit the company's web site, go to www.zimmerbiomet.com.

ZBH Valuation Summary

  • ZBH's price/earnings ratio is 34.3; this is 6.03% lower than that of the median Healthcare stock.
  • ZBH's price/sales ratio has moved down 1.1 over the prior 243 months.
  • Over the past 243 months, ZBH's price/sales ratio has gone down 1.1.

Below are key valuation metrics over time for ZBH.

Stock Date P/S P/B P/E EV/EBIT
ZBH 2021-08-31 4.0 2.5 34.3 36.2
ZBH 2021-08-30 4.0 2.5 34.1 36.1
ZBH 2021-08-27 4.0 2.5 34.2 36.1
ZBH 2021-08-26 4.0 2.5 34.1 36.0
ZBH 2021-08-25 4.0 2.5 34.3 36.2
ZBH 2021-08-24 3.9 2.5 33.9 35.9

ZBH Growth Metrics

    Its year over year revenue growth rate is now at -9.02%.
  • Its year over year cash and equivalents growth rate is now at -70.24%.
  • The 2 year cash and equivalents growth rate now stands at 37.85%.
Over the past 70 months, ZBH's revenue has gone up $1,068,800,000.

The table below shows ZBH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 7,836.2 1,499.2 401.6
2021-09-30 7,883.6 1,558.6 819.3
2021-06-30 7,888.9 1,506.8 916.2
2021-03-31 7,088.1 1,000.1 567.7
2020-12-31 7,024.5 1,204.5 -138.9
2020-09-30 7,064.9 1,202.7 -151.9

ZBH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ZBH has a Quality Grade of C, ranking ahead of 73.21% of graded US stocks.
  • ZBH's asset turnover comes in at 0.326 -- ranking 127th of 186 Medical Equipment stocks.
  • XRAY, NTUS, and TFX are the stocks whose asset turnover ratios are most correlated with ZBH.

The table below shows ZBH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.326 0.707 0.082
2021-03-31 0.295 0.696 0.051
2020-12-31 0.288 0.697 -0.005
2020-09-30 0.289 0.708 0.002
2020-06-30 0.287 0.711 -0.003
2020-03-31 0.316 0.719 0.028

ZBH Price Target

For more insight on analysts targets of ZBH, see our ZBH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $188.62 Average Broker Recommendation 1.42 (Moderate Buy)

ZBH Stock Price Chart Interactive Chart >

Price chart for ZBH

ZBH Price/Volume Stats

Current price $117.22 52-week high $153.76
Prev. close $115.00 52-week low $100.39
Day low $115.30 Volume 641,800
Day high $117.29 Avg. volume 1,549,014
50-day MA $109.43 Dividend yield 0.82%
200-day MA $121.06 Market Cap 24.60B

Zimmer Biomet Holdings Inc. (ZBH) Company Bio


Zimmer Biomet is a publicly traded medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. (Source:Wikipedia)


ZBH Latest News Stream


Event/Time News Detail
Loading, please wait...

ZBH Latest Social Stream


Loading social stream, please wait...

View Full ZBH Social Stream

Latest ZBH News From Around the Web

Below are the latest news stories about Zimmer Biomet Holdings Inc that investors may wish to consider to help them evaluate ZBH as an investment opportunity.

ZimVie to Join S&P SmallCap 600

ZimVie Inc. (NASD:ZIMV) will replace Tabula Rasa Healthcare Inc. (NASD:TRHC) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, March 2. S&P 500 constituent Zimmer Biomet Holdings Inc. (NYSE: ZBH) is spinning off ZimVie in a transaction expected to be completed on March 1. Post spin off, Zimmer Biomet Holdings will remain in the S&P 500. Tabula Rasa Healthcare is no longer representative of the small-cap market space.

Yahoo | February 23, 2022

Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2022

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2022. The cash dividend of $0.24 per share is payable on or about April 29, 2022 to stockholders of record as of the close of business on March 29, 2022.

Yahoo | February 22, 2022

Zimmer Biomet (ZBH) Business Hurt by China VBP, Price Woe

According to Zimmer Biomet (ZBH), severe customer staffing shortages and a more-than-anticipated impact of China VBP lead to dismal Q4 revenues.

Yahoo | February 15, 2022

5 Best Healthcare Stocks To Buy In 2022

On February 7, Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported earnings for the fourth quarter, posting an EPS of $1.95, missing estimates by $0.03. Zimmer Biomet Holdings, Inc.

Insider Monkey | February 14, 2022

Zimmer Biomet (ZBH) Opens New ZBEdge Centre in Singapore

Zimmer Biomet (ZBH) CEC will function as the interface between healthcare professionals and the company through engaging and interactive training across all product portfolios.

Yahoo | February 14, 2022

Read More 'ZBH' Stories Here

ZBH Price Returns

1-mo 13.25%
3-mo 2.05%
6-mo -3.63%
1-year -19.14%
3-year -11.33%
5-year 7.84%
YTD -7.34%
2021 -17.02%
2020 3.77%
2019 45.37%
2018 -13.30%
2017 17.86%

ZBH Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full ZBH Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5684 seconds.